Related Experiment Video
Updated: Jul 11, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal vaccination for patients with COPD: current practice and future directions
Jeremy G Schenkein1, Moon H Nahm, Mark T Dransfield
1The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Chest
|September 25, 2007
Summary
Pneumococcal polysaccharide vaccination for COPD patients lacks robust supporting data and demonstrated efficacy. Advances in laboratory methods and vaccine design offer promise for improved prevention against Streptococcus pneumoniae infections.
Area of Science:
- Pulmonary Medicine
- Vaccinology
- Infectious Diseases
Background:
- Pneumococcal polysaccharide vaccination is recommended for COPD patients, but supporting data and efficacy are limited.
- Current vaccines show reduced effectiveness in COPD patients compared to healthy individuals.
- Lack of adequate in vitro assays and large sample size requirements hinder clinical trials.
Purpose of the Study:
- To review existing data on pneumococcal polysaccharide vaccine use in COPD patients.
- To discuss current laboratory methods for assessing vaccine immunogenicity.
- To explore advancements in developing improved pneumococcal vaccines for COPD.
Main Methods:
- Review of clinical and laboratory studies on pneumococcal vaccination in COPD.
- Examination of available in vitro assays for vaccine immunogenicity.
- Discussion of new vaccine design strategies.
Main Results:
- Limited evidence supports the efficacy of current pneumococcal vaccines in COPD patients.
- New laboratory methods enable more accurate assessment of vaccine immunogenicity.
- Advances in vaccine technology show potential for better protection.
Conclusions:
- Improved pneumococcal vaccines are needed for effective prevention in COPD patients.
- New vaccine designs hold promise for reducing pneumonia and exacerbations caused by Streptococcus pneumoniae.
- Further research and development are crucial for optimizing vaccination strategies in COPD.
More Related Videos
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment